{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:03:28Z","timestamp":1789707808273,"version":"4.0.1"},"reference-count":42,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Recurrent pregnancy loss (RPL) is a clinically heterogeneous reproductive disorder, and in many women the underlying mechanism remains unexplained by standard thrombophilia evaluation. Pregnancy is characterized by a tightly regulated hemostatic balance at the maternal\u2013placental interface. Heparanase, tissue factor pathway inhibitor 2 (TFPI-2), and heparan sulfate (HS) are expressed in placental and hemostatic pathways and may contribute to coagulation-related pregnancy complications. We investigated whether the heparanase\/TFPI-2\/HS axis is altered in women with RPL. Blood samples were obtained from 69 women with RPL and 47 control women with at least two normal deliveries and no history of pregnancy-related vascular complications. Samples were collected at least three months after pregnancy and in the absence of hormonal therapy. Plasma and white blood cell samples were analyzed using an enzyme-linked immunosorbent assay, Western blotting, real-time polymerase chain reaction, co-immunoprecipitation, and Sanger sequencing. Mechanistic experiments using heparanase-derived peptide 16 and TFPI-2-derived peptide 6 were performed in MCF-7 and JAR cells. We found that women with RPL had increased plasma heparanase levels, heparanase procoagulant activity, HS levels, and heparanase mRNA expression compared with controls. TFPI-2 protein and mRNA expression were also elevated. The heparanase rs4693608 AA genotype was more frequent in women with RPL and, together with rs4364254 TT, was associated with increased heparanase expression and procoagulant activity. Although TFPI-2 levels were higher in RPL, co-immunoprecipitation showed reduced heparanase\/TFPI-2 complex formation, suggesting impaired inhibitory regulation. HS modulated heparanase binding to TF and TFPI-2 in a concentration-dependent, bell-shaped manner. Heparanase-derived peptide 16 increased TFPI-2 expression, supporting a regulatory feedback loop. In conclusion, RPL is associated with dysregulation of the heparanase\/TFPI-2\/HS axis, including increased heparanase expression and activity, altered heparanase\/TFPI-2 interaction, and heparanase-related genetic variation. These findings suggest a coagulation-related reproductive mechanism that may contribute to pregnancy loss and warrants validation in larger prospective studies.<\/jats:p>","DOI":"10.3390\/ijms27188210","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:33:42Z","timestamp":1789479222000},"page":"8210","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of the Heparanase\/TFPI-2\/Heparan Sulfate Axis in Recurrent Pregnancy Loss"],"prefix":"10.3390","volume":"27","author":[{"given":"Chen","family":"Yanovich","sequence":"first","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadin","family":"Sabbah","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-8667","authenticated-orcid":false,"given":"Keren","family":"Asayag","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan","family":"Crispel","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Cohen","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Keren-Politansky","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yona","family":"Nadir","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Unit, Rambam Health Care Campus, Haifa 31096, Israel"},{"name":"The Rappaport Faculty of Medicine, Technion\u2014Israel Institute of Technology, Haifa 31096, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e251\u2013257","DOI":"10.1016\/j.thromres.2009.11.026","article-title":"Involvement of Heparanase in early pregnancy losses","volume":"125","author":"Nadir","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e444\u2013450","DOI":"10.1016\/j.thromres.2010.09.007","article-title":"Involvement of heparanase in vaginal and cesarean section deliveries","volume":"126","author":"Nadir","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s43032-022-01063-1","article-title":"Maternal Thrombophilic and Hypofibrinolytic Genetic Variants in Idiopathic Recurrent Pregnancy Loss: A Continuing Mystery","volume":"30","author":"Younis","year":"2023","journal-title":"Reprod. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0042-1760332","article-title":"Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant","volume":"49","author":"Warren","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/OGX.0000000000001133","article-title":"Investigation and Management of Recurrent Pregnancy Loss: A Comprehensive Review of Guidelines","volume":"78","author":"Giouleka","year":"2023","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2012.09112.x","article-title":"Pregnancy loss and thrombophilia: The elusive link","volume":"157","author":"Bennett","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.placenta.2022.01.003","article-title":"The role of junctional adhesion molecule-C in trophoblast differentiation and function during normal pregnancy and preeclampsia","volume":"118","author":"Cao","year":"2022","journal-title":"Placenta"},{"key":"ref_8","first-page":"1264","article-title":"Decreased junctional adhesion molecule 3 expression induces reactive oxygen species production and apoptosis in trophoblastsdagger","volume":"107","author":"Chen","year":"2022","journal-title":"Biol. Reprod."},{"key":"ref_9","first-page":"M99","article-title":"Heparanase: A key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1538-7836.2006.02212.x","article-title":"Heparanase induces tissue factor expression in vascular endothelial and cancer cells","volume":"4","author":"Nadir","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0037-1608919","article-title":"Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells","volume":"99","author":"Nadir","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","article-title":"Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII","volume":"95","author":"Nadir","year":"2010","journal-title":"Haematologica"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/0008-5472.CAN-05-1811","article-title":"Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation","volume":"66","author":"Zetser","year":"2006","journal-title":"Cancer Res."},{"key":"ref_15","first-page":"579","article-title":"Heparanase mediates vascular endothelial growth factor gene transcription in high-glucose human retinal microvascular endothelial cells","volume":"23","author":"Hu","year":"2017","journal-title":"Mol. Vis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41389-018-0060-8","article-title":"Identification of strong intron enhancer in the heparanase gene: Effect of functional rs4693608 variant on HEPARANASE enhancer activity in hematological and solid malignancies","volume":"7","author":"Ostrovsky","year":"2018","journal-title":"Oncogenesis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102179","DOI":"10.1016\/j.rpth.2023.102179","article-title":"Tissue factor-heparanase complex: Intracellular nonhemostatic effects","volume":"7","author":"Ghanem","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.placenta.2019.01.011","article-title":"Increased placental expression of Placental Protein 5 (PP5)\/Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?","volume":"76","author":"Karaszi","year":"2019","journal-title":"Placenta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1189\/jlb.1208735","article-title":"Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: Possibility of multiple levels of heparanase regulation","volume":"86","author":"Ostrovsky","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e317\u2013322","DOI":"10.1016\/j.thromres.2010.02.017","article-title":"Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy","volume":"125","author":"Xiong","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2017.02.005","article-title":"Hypomethylation of tissue factor pathway inhibitor 2 in human placenta of preeclampsia","volume":"152","author":"Xiao","year":"2017","journal-title":"Thromb. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.thromres.2011.03.008","article-title":"An assay to evaluate heparanase procoagulant activity","volume":"128","author":"Nadir","year":"2011","journal-title":"Thromb. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.thromres.2011.09.021","article-title":"Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin","volume":"130","author":"Peled","year":"2012","journal-title":"Thromb. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/humrep\/det257","article-title":"Heparanase procoagulant activity is elevated in women using oral contraceptives","volume":"28","author":"Matan","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_25","first-page":"61","article-title":"Progestin type affects the increase of heparanase level and procoagulant activity mediated by the estrogen receptor","volume":"36","author":"Treger","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2014.07.023","article-title":"Evaluation of glycosaminoglycans and heparanase in placentas of women with preeclampsia","volume":"437","author":"Fama","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1634\/theoncologist.2017-0530","article-title":"Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study","volume":"23","author":"Syrigos","year":"2018","journal-title":"Oncologist"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2012.09.018","article-title":"Heparanase role in the treatment of avascular necrosis of femur head","volume":"131","author":"Peled","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2016.01.014","article-title":"Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation","volume":"139","author":"Peled","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jth.13707","article-title":"Involvement of the heparanase procoagulant domain in bleeding and wound healing","volume":"15","author":"Crispel","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/ejh.14060","article-title":"Effects of anti-Xa activity monitoring on the outcome of high-risk pregnancies treated with a prophylactic dose of low-molecular-weight heparin","volume":"111","author":"Nasich","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/hematology.2024000672","article-title":"Inherited thrombophilia and recurrent miscarriage: Is there a role for anticoagulation during pregnancy?","volume":"2024","author":"Padrnos","year":"2024","journal-title":"Hematology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jtha.2025.02.018","article-title":"An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: Guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies: Reply","volume":"23","author":"Devreese","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40364-024-00598-6","article-title":"Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders","volume":"12","author":"Ji","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40364-024-00557-1","article-title":"DeepMPTB: A vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction","volume":"12","author":"Chakoory","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1242\/jcs.01068","article-title":"Processing and activation of latent heparanase occurs in lysosomes","volume":"117","author":"Zetser","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH13-12-1049","article-title":"Novel peptides that inhibit heparanase activation of the coagulation system","volume":"112","author":"Axelman","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbrc.2006.01.048","article-title":"An ELISA method for the detection and quantification of human heparanase","volume":"341","author":"Shafat","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1999.00591.x","article-title":"Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy","volume":"56","author":"Yokoyama","year":"1999","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thoraxjnl-2018-212964","article-title":"Heparan sulfate chains contribute to the anticoagulant milieu in malignant pleural effusion","volume":"75","author":"Hardak","year":"2020","journal-title":"Thorax"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/en.2013-1759","article-title":"Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction","volume":"155","author":"Damerill","year":"2014","journal-title":"Endocrinology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D\u2019D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8210\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:16:17Z","timestamp":1789704977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":42,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188210"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188210","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}